Sunandana Chandra, MD, MS, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, highlights data coming from a study looking at the long-term follow up of lifileucel (LN-144) cryopreserved autologous tumor infiltrating lymphocyte therapy in patients with advanced melanoma who had progressed following multiple prior therapies. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).